Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 66876 - 66900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Romidepsin	Approved Investigational	NR1I3	9970	upregulated	romidepsin results in increased expression of NR1I3 mRNA	1q23.3	A24093
Romidepsin	Approved Investigational	VEGFA	7422	downregulated	romidepsin results in decreased expression of VEGFA mRNA	6p21.1	A24094
Rosiglitazone	Approved Investigational	AADAC	13	upregulated	rosiglitazone results in increased expression of AADAC mRNA	3q25.1	A22609
Rosiglitazone	Approved Investigational	AASS	10157	downregulated	rosiglitazone results in decreased expression of AASS mRNA	7q31.32	A22609
Rosiglitazone	Approved Investigational	ABAT	18	downregulated	rosiglitazone results in decreased expression of ABAT mRNA	16p13.2	A22609
Rosiglitazone	Approved Investigational	ABCA1	19	upregulated	rosiglitazone results in increased expression of ABCA1 mRNA	9q31.1	A20966
Rosiglitazone	Approved Investigational	ABCA8	10351	downregulated	rosiglitazone results in decreased expression of ABCA8 mRNA	17q24.2	A22609
Rosiglitazone	Approved Investigational	ABCC2	1244	upregulated	rosiglitazone results in increased expression of ABCC2 mRNA	10q24.2	A22609
Rosiglitazone	Approved Investigational	ABCC6	368	downregulated	rosiglitazone results in decreased expression of ABCC6 mRNA	16p13.11	A22609
Rosiglitazone	Approved Investigational	ABCC6P1	653190	downregulated	rosiglitazone results in decreased expression of ABCC6P1 mRNA	16p12.3	A22609
Rosiglitazone	Approved Investigational	ACAT1	38	downregulated	rosiglitazone results in decreased expression of ACAT1 mRNA	11q22.3	A23649
Rosiglitazone	Approved Investigational	ACOX1	51	upregulated	rosiglitazone results in increased expression of ACOX1 mRNA	17q25.1	A24095
Rosiglitazone	Approved Investigational	ACSM5	54988	downregulated	rosiglitazone results in decreased expression of ACSM5 mRNA	16p12.3	A22609
Rosiglitazone	Approved Investigational	ACY1	95	downregulated	rosiglitazone results in decreased expression of ACY1 mRNA	3p21.2	A22609
Rosiglitazone	Approved Investigational	ADA	100	upregulated	rosiglitazone results in increased expression of ADA mRNA	20q13.12	A10216
Rosiglitazone	Approved Investigational	ADCY1	107	downregulated	rosiglitazone results in decreased expression of ADCY1 mRNA	7p12.3	A20427
Rosiglitazone	Approved Investigational	ADGRG1	9289	upregulated	rosiglitazone results in increased expression of ADGRG1 mRNA	16q21	A22609
Rosiglitazone	Approved Investigational	ADH4	127	downregulated	rosiglitazone results in decreased expression of ADH4 mRNA	4q23	A22609
Rosiglitazone	Approved Investigational	ADH6	130	downregulated	rosiglitazone results in decreased expression of ADH6 mRNA	4q23	A22609
Rosiglitazone	Approved Investigational	ADIPOQ	9370	upregulated	rosiglitazone results in increased expression of ADIPOQ mRNA	3q27.3	A24096 A24097 A24098
Rosiglitazone	Approved Investigational	ADIPOR2	79602	upregulated	rosiglitazone results in increased expression of ADIPOR2 mRNA	12p13.33	A24099
Rosiglitazone	Approved Investigational	AFM	173	downregulated	rosiglitazone results in decreased expression of AFM mRNA	4q13.3	A22609
Rosiglitazone	Approved Investigational	AGMO	392636	downregulated	rosiglitazone results in decreased expression of AGMO mRNA	7p21.2	A22609
Rosiglitazone	Approved Investigational	AGPAT4	56895	upregulated	rosiglitazone results in increased expression of AGPAT4 mRNA	6q26	A10216
Rosiglitazone	Approved Investigational	AGRN	375790	downregulated	rosiglitazone results in decreased expression of AGRN mRNA	1p36.33	A10216

Displaying entries 66876 - 66900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability